跳至主要内容
临床试验/NL-OMON48700
NL-OMON48700已完成不适用

Tinnitus pitch matching by residual inhibition and contrast gain control. - Tinnitus pitch matching

niversitair Medisch Centrum Groningen0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Tinnitus group (A, n=20):
  • - No reported neurological or psychiatric disorders (excluding tinnitus and
  • hearing loss);
  • - Chronic tinnitus (lasting more than 6 months);
  • - Adult, 18-75 years of age;
  • - Symmetric hearing loss with PTA (average threshold 1000-2000-4000 Hz) >= 30 dB;
  • - Written informed consent;
  • Hearing loss group (B, n=20):
  • - No reported neurological or psychiatric disorders (excluding hearing loss);
  • - Adult, 18-75 years of age;
  • - Symmetric hearing loss with PTA (average threshold 1000-2000-4000 Hz) >= 30 dB;
  • - Written informed consent;
  • Control group (C, n=20)
  • - Healthy subjects (i.e., excluding tinnitus, no medical, neurological, or
  • psychiatric disorders);
  • - Adult, 18-75 years of age;
  • - Normal hearing thresholds or mild hearing loss (average threshold <=20 dB @
  • 500-2000 Hz);
  • - <=30 dB difference between both ears for all the standard audiometric
  • frequencies;
  • - Written informed consent;

排除标准

  • - All subjects who cannot fully understand the experimental task.
  • - Non-conformance to any of the inclusion criteria stated above.

研究者

相似试验